External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home EAHAD 2026
Roche and Genentech at

EAHAD 2026

February 03 - February 06
Dublin, Ireland
eahadcongress.com
We will be contributing to topics related to
Haematology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
01:00 PM
Duration 60mins Dublin, Ireland
Advancing Haemophilia A Care : Exploring Current and Future Horizons of FVIII Mimetics
Cedric Hermans, Davide Matino, Priyanka Raheja
Haematology | Hemophilia

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:30 PM
Duration 60mins Dublin, Ireland
Evolution of joint health and physical activity in people with haemophilia A without factor VIII inhibitors switching to emicizumab prophylaxis: 12-month interim analysis of the BEYOND ABR study
Di Minno M, Kruse-Jarres R, Castaman G, Stephensen D, Lobet S, Barlera S, Brocchieri C, Jiménez-Yuste V
Haematology | Hemophilia A without Inhibitor

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Dublin, Ireland
Emicizumab prophylaxis in the paediatric population: an update on longitudinal follow-up data
Kenet G, Anderson N,Blatný J, Carcao M, Chang A, d'Oiron R, Escuriola-Ettingshausen C, Fischer K, Königs C, Labarque V, Meng M, Motwani J, Niggli M, Nolan B, Olivieri M, Pinto F, Polito L, Ranta S, Van Geet C, Zápotocká E, Male C
Haematology | Hemophilia A

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:00 PM
Duration 15mins Ireland
Safety, Pharmacodynamics, and Efficacy of NXT007 After Switching from Emicizumab in Hemophilia A with and without inhibitors (NXTAGE Part C)
Nogami K, Chou S-C, Nagae C, Higasa S, Takeyama M, Shen M-C, You C-W, Miwa T, Chen C-A, Miyake T, Aizawa Y, Shima M
Haematology | Hemophilia

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.